Levels of serum CCL11 and LCN-2 in non-small cell lung cancer patients and their diagnostic value
10.3969/j.issn.1673-4130.2024.14.016
- VernacularTitle:非小细胞肺癌患者血清CCL11、LCN-2水平及其诊断价值
- Author:
Xiaoou HUO
1
;
Zhijun ZHANG
;
Huidong LIU
Author Information
1. 太原市中心医院(北京大学第一医院太原医院)肿瘤科,山西太原 030009
- Keywords:
non-small cell lung cancer;
CC chemokine ligand-11;
lipocalin-2;
diagnostic value
- From:
International Journal of Laboratory Medicine
2024;45(14):1745-1749,1755
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the levels of serum CC chemokine ligand-11(CCL11)and lipocalin-2(LCN-2)in patients with non-small cell lung cancer(NSCLC)and their diagnostic value for NSCLC.Methods NSCLC pa-tients admitted to the hospital from October 2019 to December 2022 were collected as the NSCLC group(80 cases),and 80 patients with benign lung lesions and 80 healthy volunteers treated in the hospital during the same period were collected as benign control group and health control group.Enzyme linked immunosorbent assay(ELISA)was applied to measure serum levels of CCL11 and LCN-2.The general data and serum levels of CCL11 and LCN-2 were compared among the three groups.Receiver operating characteristic(ROC)curve was applied to analyze the diagnostic value of serum CCL11 and LCN-2 for NSCLC.Logistic regression was applied to analyze the influencing factors of the occurrence of NSCLC.Results The serum levels of CCL11 and LCN-2 in NSCLC group were obviously higher than those in benign control group and health control group(P＜0.05),but there was no statistically significant difference between begin control group and health control group(P＞0.05).There was no statistically significant difference in serum CCL11 and LCN-2 levels among NSCLC patients of different genders,ages,and pathological types(P＞0.05),the serum levels of CCL11 and LCN-2 in NSCLC patients with a history of smoking,engaged in work related oil smoke at dust,medium to low differentiation,tumor diameter＞3 cm,lymph node metastasis,and TNM staging Ⅲ-Ⅳ were obviously higher than those in NSCLC patients without a history of smoking,not engaged in work related oil smoke at dust,high differentiation,tumor diameter ≤3 cm,non lymph node metastasis,and TNM stagingⅠ-Ⅱ(P＜0.05).The results of ROC curve showed that the area under the curve(AUC)of CCL11,LCN-2 alone and their combination in the diagnosis of NSCLC was 0.849,0.841 and 0.926 respectively,the sensitivi-ty was 73.8％,75.0％and 85.0％respectively,and the specificity was 70.1％,70.0％and 75.0％respective-ly.The efficacy of combined detection of the two in diagnosing NSCLC was better than those of single detec-tion(P＜0.05).The results of Logistic regression analysis showed that smoking,engaging in high oil fume,dust related works,and serum levels of CCL11 and LCN-2 were all influencing factors for the occurrence of NSCLC(P＜0.05).Conclusion In NSCLC patients,the levels of serum CCL11 and LCN-2 obviously in-crease,and they are closely related to the clinical pathological characteristics of NSCLC patients.Both have certain clinical value in the diagnosis of NSCLC.
